Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Jovin J. Y. Choo, Christopher L. D. McMillan, Paul R. Young & David A. Muller. (2023) Microarray patches: scratching the surface of vaccine delivery. Expert Review of Vaccines 22:1, pages 937-955.
Read now
Read now
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Nguyen-Minh-An Tran, Huy Truong Nguyen & Giau Van Vo. (2022) Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses. Pharmaceutical Development and Technology 27:1, pages 83-94.
Read now
Read now
Thuy Trang Nguyen & Jung Hwan Park. (2018) Human studies with microneedles for evaluation of their efficacy and safety. Expert Opinion on Drug Delivery 15:3, pages 235-245.
Read now
Read now
Yeu-Chun Kim, Su-Hwa Lee, Won-Hyung Choi, Hyo-Jick Choi, Tae-Won Goo, Ju-Hie Lee & Fu-Shi Quan. (2016) Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. Journal of Drug Targeting 24:10, pages 943-951.
Read now
Read now
Yotam Levin, Efrat Kochba, Ivan Hung & Richard Kenney. (2015) Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future. Human Vaccines & Immunotherapeutics 11:4, pages 991-997.
Read now
Read now
Sang Hoon Han, Jun Hee Woo, Francoise Weber, Woo Joo Kim, Kyong Ran Peck, Sang Il Kim, Young Hwa Choi & June Myung Kim. (2013) Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial. Human Vaccines & Immunotherapeutics 9:9, pages 1971-1977.
Read now
Read now
Filippo Ansaldi, Andrea Orsi, Daniela de Florentiis, Valentina Parodi, Emanuela Rappazzo, Martina Coppelli, Paolo Durando & Giancarlo Icardi. (2013) Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60. Human Vaccines & Immunotherapeutics 9:3, pages 591-598.
Read now
Read now
Andrea Orsi, Filippo Ansaldi, Daniela de Florentiis, Antonella Ceravolo, Valentina Parodi, Paola Canepa, Martina Coppelli, Giancarlo Icardi & Paolo Durando. (2013) Cross-protection against drifted influenza viruses. Human Vaccines & Immunotherapeutics 9:3, pages 582-590.
Read now
Read now
Isabel Leroux-Roels & Françoise Weber. (2013) Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Human Vaccines & Immunotherapeutics 9:1, pages 115-121.
Read now
Read now
Jukka Hartikka, Vesselina Bozoukova, Jane Morrow, Denis Rusalov, Mark Shlapobersky, Qun Wei, Sou Boutsaboualoy, Ming Ye, Mary K. Wloch, John Doukas, Sean M. Sullivan, Alain Rolland & Larry R. Smith. (2012) Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. Human Vaccines & Immunotherapeutics 8:11, pages 1595-1606.
Read now
Read now
Filippo Ansaldi, Laura Valle, Daniela de Florentiis, Valentina Parodi, Giuseppe Murdaca, Bianca M. Bruzzone, Paolo Durando, Maurizio Setti & Giancarlo Icardi. (2012) Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine vs. standard-dose intramuscular vaccine in HIV-1-infected adults. Human Vaccines & Immunotherapeutics 8:8, pages 1048-1052.
Read now
Read now
Giancarlo Icardi, Andrea Orsi, Antonella Ceravolo & Filippo Ansaldi. (2012) Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. Human Vaccines & Immunotherapeutics 8:1, pages 67-75.
Read now
Read now
Filippo Ansaldi, Daniela de Florentiis, Paolo Durando & Giancarlo Icardi. (2012) Fluzone® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults. Expert Review of Vaccines 11:1, pages 17-25.
Read now
Read now
Filippo Ansaldi, Paolo Durando & Giancarlo Icardi. (2011) Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opinion on Biological Therapy 11:3, pages 415-427.
Read now
Read now
Robert L Atmar, Shital M Patel & Wendy A Keitel. (2010) Intanza®: a new intradermal vaccine for seasonal influenza. Expert Review of Vaccines 9:12, pages 1399-1409.
Read now
Read now
Articles from other publishers (50)
Wen‐jie Cheng, Zi‐xing Cai & Xiao‐jun Tang. (2023)
Adverse reactions to cosmetic implants after
COVID
‐19 vaccination: A literature review
. Journal of Cosmetic Dermatology 22:12, pages 3199-3212.
Crossref
Crossref
Huiting Zhao, Peixuan Li, Lijun Bian, Wen Zhang, Chunlai Jiang, Yan Chen, Wei Kong & Yong Zhang. (2023) Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice. International Journal of Molecular Sciences 24:17, pages 13587.
Crossref
Crossref
Sarah H. Park, Lin Lei, Darrel D’Souza, Robert Zipkin, Emily T. DiMartini, Maria Atzampou, Emran O. Lallow, Jerry W. Shan, Jeffrey D. Zahn, David I. Shreiber, Hao Lin, Joel N. Maslow & Jonathan P. Singer. (2023) Efficient electrospray deposition of surfaces smaller than the spray plume. Nature Communications 14:1.
Crossref
Crossref
Renuka Roche, Nouha H. Odeh, Abhay U. Andar, Mohan E. Tulapurkar & Joseph A. Roche. (2023) Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19. Microorganisms 11:8, pages 1963.
Crossref
Crossref
Darin Zehrung, Courtney Jarrahian & Manjari Lal. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1397
1431.e18
.
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines
514
551.e31
.
Xinghan Chen, Haitao Xiao, Qiao Zhao, Xuewen Xu, Ying Cen & Dongqin Xiao. (2022) Research hotspot and trend of microneedles in biomedical field: A bibliometric analysis from 2011 to 2020. Burns 48:4, pages 959-972.
Crossref
Crossref
Hiroya Abe, Kaito Sato, Natsumi Kimura, Shinya Kusama, Daisuke Inoue, Kenshi Yamasaki & Matsuhiko Nishizawa. (2021) Porous Microneedle Patch for Electroosmosis‐Promoted Transdermal Delivery of Drugs and Vaccines. Advanced NanoBiomed Research 2:1.
Crossref
Crossref
Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett & Tom Noseworthy. (2021) Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines. JAMA Network Open 4:2, pages e2035693.
Crossref
Crossref
Shilpa R. Jain & Deepali Kumar. 2021. Emerging Transplant Infections. Emerging Transplant Infections
253
284
.
Ramiro L. Gutiérrez, Chad K. Porter, Abel Jarell, Ashley Alcala, Mark S. Riddle & George W. Turiansky. (2020) A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine. Vaccine 38:21, pages 3773-3779.
Crossref
Crossref
Ciying Qian, Xinlin Liu, Qin Xu, Zhiping Wang, Jie Chen, Tingting Li, Qingbing Zheng, Hai Yu, Ying Gu, Shaowei Li & Ningshao Xia. (2020) Recent Progress on the Versatility of Virus-Like Particles. Vaccines 8:1, pages 139.
Crossref
Crossref
Shilpa R. Jain & Deepali Kumar. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
32
.
Matthew R. Beymer, Ian W. Holloway, Craig Pulsipher & Raphael J. Landovitz. (2019) Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals. Current HIV/AIDS Reports 16:4, pages 349-358.
Crossref
Crossref
Ryan F. Donnelly & Eneko Larrañeta. (2018) Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. Drug Discovery Today 23:5, pages 1026-1033.
Crossref
Crossref
Vittorio Demicheli, Tom Jefferson, Eliana Ferroni, Alessandro Rivetti & Carlo Di Pietrantonj. (2018) Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2020:2.
Crossref
Crossref
Mark J. Papania, Darin Zehrung & Courtney Jarrahian. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1320
1353.e17
.
Joseph S. Bresee, Alicia M. Fry, Suryaprakash Sambhara & Nancy J. Cox. 2018. Plotkin's Vaccines. Plotkin's Vaccines
456
488.e21
.
Haripriya Kalluri, Seong-O Choi, Xin Dong Guo, Jeong Woo Lee, James Norman & Mark R. Prausnitz. 2017. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement
325
340
.
Eneko Larrañeta, Rebecca E.M. Lutton, A. David Woolfson & Ryan F. Donnelly. (2016) Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Materials Science and Engineering: R: Reports 104, pages 1-32.
Crossref
Crossref
Sarah Marshall, Laura J. Sahm & Anne C. Moore. (2016) Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use. Vaccine 34:6, pages 723-734.
Crossref
Crossref
Ryo Arakane, Hitomi Nakatani, Emi Fujisaki, Akiko Takahama, Katsuyasu Ishida, Michiharu Yoshiike, Tetsuo Nakayama & Fumihiko Takeshita. (2015) Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial. Vaccine 33:46, pages 6340-6350.
Crossref
Crossref
Claudia Pileggi, Valentina Mascaro, Aida Bianco, Carmelo G. A. Nobile & Maria Pavia. (2015) Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials. Drugs & Aging 32:10, pages 857-869.
Crossref
Crossref
Raúl Ortiz de Lejarazu & Sonia Tamames. (2015) Vacunación antigripal. Efectividad de las vacunas actuales y retos de futuro. Enfermedades Infecciosas y Microbiología Clínica 33:7, pages 480-490.
Crossref
Crossref
Jenny G.H. Low, Lawrence S. Lee, Eng Eong Ooi, Kantharaj Ethirajulu, Pauline Yeo, Alex Matter, John E. Connolly, David A.G. Skibinski, Philippe Saudan, Martin Bachmann, Brendon J. Hanson, Qingshu Lu, Sebastian Maurer-Stroh, Sam Lim & Veronica Novotny-Diermayr. (2014) Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers. Vaccine 32:39, pages 5041-5048.
Crossref
Crossref
Tuen-Ching Chan, Ivan Fan-Ngai Hung, Kwok-Hung Chan, Clara Pui-Yan Li, Patrick Tsz-Wai Li, James Ka-Hay Luk, Leung-Wing Chu & Felix Hon-Wai Chan. (2014) Immunogenicity and Safety of Intradermal Trivalent Influenza Vaccination in Nursing Home Older Adults: A Randomized Controlled Trial. Journal of the American Medical Directors Association 15:8, pages 607.e5-607.e12.
Crossref
Crossref
James J. Norman, Jaya M. Arya, Maxine A. McClain, Paula M. Frew, Martin I. Meltzer & Mark R. Prausnitz. (2014) Microneedle patches: Usability and acceptability for self-vaccination against influenza. Vaccine 32:16, pages 1856-1862.
Crossref
Crossref
Vittorio Demicheli, Tom Jefferson, Lubna A Al-Ansary, Eliana Ferroni, Alessandro Rivetti & Carlo Di Pietrantonj. (2014) Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Fu-Shi Quan, Yeu-Chun Kim, Jae-Min Song, Hye Suk Hwang, Richard W. Compans, Mark R. Prausnitz & Sang-Moo Kang. (2013) Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch. Clinical and Vaccine Immunology 20:9, pages 1433-1439.
Crossref
Crossref
Fawziah Marra, Flora Young, Kathryn Richardson & Carlo A. Marra. (2013) A Meta-analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events. Influenza and Other Respiratory Viruses 7:4, pages 584-603.
Crossref
Crossref
Darin Zehrung, Courtney Jarrahian & Amy Wales. (2013) Intradermal delivery for vaccine dose sparing: Overview of current issues. Vaccine 31:34, pages 3392-3395.
Crossref
Crossref
A. Baluch, A. Humar, D. Eurich, A. Egli, A. Liacini, K. Hoschler, P. Campbell, N. Berka, S. Urschel, L. Wilson & D. Kumar. (2013) Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients. American Journal of Transplantation 13:4, pages 1026-1033.
Crossref
Crossref
Joon Young SongHee Jin CheongJi Yun NohTae Un YangYu Bin SeoKyung-Wook HongIn Seon KimWon Suk ChoiWoo Joo Kim. (2013) Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults. Clinical and Experimental Vaccine Research 2:2, pages 115.
Crossref
Crossref
Bruce G. Weniger & Mark J. Papania. 2013. Vaccines. Vaccines
1200
1231
.
Steven G. Self. 2013. Proceedings of the Fourth Seattle Symposium in Biostatistics: Clinical Trials. Proceedings of the Fourth Seattle Symposium in Biostatistics: Clinical Trials
35
46
.
Brenda L. Coleman, Allison J. McGeer, Scott A. Halperin, Joanne M. Langley, Yassein Shamout, Anna Taddio, Vibhuti Shah & Shelly A. McNeil. (2012) A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine 30:44, pages 6287-6293.
Crossref
Crossref
Ronald J PettisAlfred J Harvey. (2012) Microneedle delivery: clinical studies and emerging medical applications. Therapeutic Delivery 3:3, pages 357-371.
Crossref
Crossref
Anushree Herwadkar & Ajay K Banga. (2012) An update on the application of physical technologies to enhance intradermal and transdermal drug delivery. Therapeutic Delivery 3:3, pages 339-355.
Crossref
Crossref
Katherine S. Nelson, Julia M. Janssen, Stephanie B. Troy & Yvonne Maldonado. (2012) Intradermal fractional dose inactivated polio vaccine: A review of the literature. Vaccine 30:2, pages 121-125.
Crossref
Crossref
Roman Prymula, Gaye Usluer, Serdar Altinel, Radka Sichova & Françoise Weber. (2012) Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey. Advances in Therapy 29:1, pages 41-52.
Crossref
Crossref
Flora Young & Fawziah Marra. (2011) A systematic review of intradermal influenza vaccines. Vaccine 29:48, pages 8788-8801.
Crossref
Crossref
Jyoti Gupta, Sohyun S. Park, Brian Bondy, Eric I. Felner & Mark R. Prausnitz. (2011) Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials 32:28, pages 6823-6831.
Crossref
Crossref
Tara Harris & Dr. Nadine Sicard. (2011) Addendum to the 2010-2011 Seasonal Trivalent Inactivated Influenza Vaccine. Canada Communicable Disease Report 37:ACS-4, pages 1-39.
Crossref
Crossref
Robert W. FrenckJr.Jr., Robert Belshe, Rebecca C. Brady, Patricia L. Winokur, James D. Campbell, John Treanor, Christine M. Hay, Cornelia L. Dekker, Emmanuel B. WalterJr.Jr., Thomas R. Cate, Kathryn M. Edwards, Heather Hill, Mark Wolff, Tom LeDuc & Nadia Tornieporth. (2011) Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 29:34, pages 5666-5674.
Crossref
Crossref
Robert Arnou, Matthias Frank, Thomas Hagel & Alice Prébet. (2011) Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Advances in Therapy 28:7, pages 555-565.
Crossref
Crossref
JK HicklingKR JonesM FriedeD ZehrungD ChenD Kristensen. (2011) Intradermal delivery of vaccines: potential benefits and current challenges. Bulletin of the World Health Organization 89:3, pages 221-226.
Crossref
Crossref
Valentina Parodi, Daniela de Florentiis, Mariano Martini & Filippo Ansaldi. (2011) Inactivated Influenza Vaccines. Drugs & Aging 28:2, pages 93-106.
Crossref
Crossref
J.R. De Juanes Pardo, M.P. Arrazola Martínez & A. García de Codes Ilario. (2010) Vacunación frente a la gripe por vía intradérmica. Vacunas 11:4, pages 143-145.
Crossref
Crossref
Jean-Pierre Amorij, Wouter LJ Hinrichs, Henderik W Frijlink, Jan C Wilschut & Anke Huckriede. (2010) Needle-free influenza vaccination. The Lancet Infectious Diseases 10:10, pages 699-711.
Crossref
Crossref
Sean T. Duggan & Greg L. Plosker. (2010) Intanza® 15 μg Intradermal Seasonal Influenza Vaccine. Drugs & Aging 27:7, pages 597-605.
Crossref
Crossref